Are You or Your Child Facing Challenges Due to CAH?

These clinical research studies may interest you.

See if you may qualify

Studies at a Glance

We are currently enrolling children and adults ages 1 to 74 who have been diagnosed with classic congenital adrenal hyperplasia (CAH). The Calm-CAH (adult) and Balance-CAH (pediatric) studies are looking to understand the safety and effectiveness of an investigational study drug, atumelnant, whether it may reduce the dosage needed for steroid medications like glucocorticoids (GCs), and how it may help manage symptoms of CAH. If you or your child is interested in taking part in this research, please complete the questionnaire to determine eligibility.

Learn More About These Studies:

For adults ages 18–74

For children ages 1–17

See If You May Qualify

Step 1 of 3

By answering the following questions, you or your child are not obligated to participate in this clinical research study. At the end of the questionnaire, you will have the opportunity to decide whether your answers are saved or submitted to a local research center to discuss the study further. If you are younger than 18, you will need your parent or guardian to complete this prescreener on your behalf.

Do you want to proceed?
I am completing this questionnaire on behalf of:

e.g., 12345

MM/YYYY

This website uses Secure Socket Layer technology and encryption methods to protect personal health information. If you’d like to know more about this, read the privacy policy.

Calm-CAH

For adults ages 18–74 diagnosed with classic CAH.

Learn more about this study

Balance-CAH

For children and adolescents ages 1–17 diagnosed with classic CAH.

Learn more about this study

Crinetics Pharmaceuticals is committed to conducting studies that reflect the diversity of our community. We believe that including participants from various backgrounds is crucial for ensuring that our medicines work for everyone who may need it.